Influenza virus infection in infancy and early childhood
- PMID: 12758046
Influenza virus infection in infancy and early childhood
Abstract
Infants and young children have the highest influenza infection and hospitalisation rates in paediatrics. The immaturity of the infant's immune system and the absence of prior immunity and exposure to the virus are potential contributors. Although most children that suffer from influenza infection are otherwise healthy, an underlying chronic medical condition further increases the risk for complications. Annual immunisation with influenza vaccine is recommended for any child 6 months of age and older in whom prevention of disease is desirable, particularly for those with underlying medical conditions. Offering influenza vaccine to pregnant women who will deliver during the influenza season can potentially reduce the frequency and severity of influenza disease in infants less than 6 months of age. Family members, including other children and all other close contacts, should also receive influenza vaccine to reduce transmission to children at risk and infants in the first 6 months of life.
Similar articles
-
Prevention of influenza: recommendations for influenza immunization of children, 2007-2008.Pediatrics. 2008 Apr;121(4):e1016-31. doi: 10.1542/peds.2008-0160. Pediatrics. 2008. PMID: 18381500 Review.
-
Severe pediatric influenza in California, 2003-2005: implications for immunization recommendations.Pediatrics. 2006 Apr;117(4):e610-8. doi: 10.1542/peds.2005-1373. Pediatrics. 2006. PMID: 16585278
-
Antiviral drugs in influenza: an adjunct to vaccination in some situations.Prescrire Int. 2006 Feb;15(81):21-30. Prescrire Int. 2006. PMID: 16548114
-
Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents.J Infect Dis. 2006 Nov 1;194 Suppl 2:S133-8. doi: 10.1086/507548. J Infect Dis. 2006. PMID: 17163386
-
Influenza virus pneumonia: pathogenesis, treatment, and prevention.Semin Respir Infect. 1995 Dec;10(4):216-23. Semin Respir Infect. 1995. PMID: 8668849 Review.
Cited by
-
Challenges for the Newborn Following Influenza Virus Infection and Prospects for an Effective Vaccine.Front Immunol. 2020 Sep 16;11:568651. doi: 10.3389/fimmu.2020.568651. eCollection 2020. Front Immunol. 2020. PMID: 33042150 Free PMC article. Review.
-
Influenza-infected newborn and adult monkeys exhibit a strong primary antibody response to hemagglutinin stem.JCI Insight. 2020 Mar 12;5(5):e135449. doi: 10.1172/jci.insight.135449. JCI Insight. 2020. PMID: 32078584 Free PMC article.
-
Understanding Antibody Responses in Early Life: Baby Steps towards Developing an Effective Influenza Vaccine.Viruses. 2021 Jul 17;13(7):1392. doi: 10.3390/v13071392. Viruses. 2021. PMID: 34372597 Free PMC article. Review.
-
Comparison of the clinical effectiveness of zanamivir and laninamivir octanoate for children with influenza A(H3N2) and B in the 2011-2012 season.Influenza Other Respir Viruses. 2014 Mar;8(2):151-8. doi: 10.1111/irv.12147. Epub 2013 Aug 19. Influenza Other Respir Viruses. 2014. PMID: 23953886 Free PMC article.
-
TLR agonists induce sustained IgG to hemagglutinin stem and modulate T cells following newborn vaccination.NPJ Vaccines. 2022 Aug 29;7(1):102. doi: 10.1038/s41541-022-00523-8. NPJ Vaccines. 2022. PMID: 36038596 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical